Medication info
Englina Tablet 25/5 mg (Empagliflozin, Linagliptin)

Englina Tablet 25/5 mg (Empagliflozin, Linagliptin)

Prescription medicationTabletOral
Ingredient · strength
Linagliptin Micronized›5mg / 1 tabletEmpagliflozin Amorphous›25mg / 1 tablet
Manufacturer / importer
Daehwa Pharmaceutical Co., Ltd.
Appearance
Pink film-coated tablet with a biconvex round shape
Packaging
Bottle - 30 tablets/bottle, Bottle - 100 tablets/bottle
Approval status
Active

MFDS item code 202501684 · Approved 2025.07.07 · Insurance code 645606000

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The recommended starting dose of this medicine is empagliflozin 10 mg/linagliptin 5 mg once daily. If empagliflozin 10 mg/linagliptin 5 mg is tolerated and additional glycemic control is needed, the dose of this medicine may be increased to 25/5 mg once daily. Patients switching to this medicine from combination therapy with empagliflozin and linagliptin should receive their previous doses. This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. However, if it is within 12 hours of your next dose, skip the missed dose and take your next dose at the usual time. Do not take a double dose in one day. Patients with renal impairment This medicine is not recommended to improve glycemic control in patients with an estimated glomerular filtration rate (eGFR) below 45 ml/min/1.73m2. No dose adjustment is required for patients with an eGFR of 45 ml/min/1.73m2 or higher. Patients with hepatic impairment No dose adjustment is required in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment because it has not been studied in this population. Elderly patients No dose adjustment based on age is required. Renal function and the risk of volume depletion should be considered in patients aged 75 years or older.

Ingredients

Manufacturer
Daehwa Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes mellitus

View approved original text

This medication is taken in conjunction with diet and exercise to help patients with type 2 diabetes manage their blood sugar levels. The combined action of the ingredients, Empagliflozin and Linagliptin, effectively lowers blood sugar. Therefore, it is helpful in the treatment of blood sugar management.

How to take

Adult dose

The recommended starting dose of this medicine is empagliflozin 10 mg/linagliptin 5 mg once daily. If empagliflozin 10 mg/linagliptin 5 mg is tolerated and additional glycemic control is needed, the dose of this medicine may be increased to 25/5 mg once daily. Patients switching to this medicine from combination therapy with empagliflozin and linagliptin should receive their previous doses. This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. However, if it is within 12 hours of your next dose, skip the missed dose and take your next dose at the usual time. Do not take a double dose in one day. Patients with renal impairment This medicine is not recommended to improve glycemic control in patients with an estimated glomerular filtration rate (eGFR) below 45 ml/min/1.73m2. No dose adjustment is required for patients with an eGFR of 45 ml/min/1.73m2 or higher. Patients with hepatic impairment No dose adjustment is required in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment because it has not been studied in this population. Elderly patients No dose adjustment based on age is required. Renal function and the risk of volume depletion should be considered in patients aged 75 years or older.

Precautions

This medication contains two components, Empagliflozin and Linagliptin, which help manage blood sugar levels. This medication should not be used by individuals allergic to Empagliflozin, Linagliptin, or other components, patients with type 1 diabetes, those with diabetic ketoacidosis, or patients undergoing dialysis. For patients with impaired renal function, the effect of this medication may vary; thus, it is important to undergo regular kidney function tests before and during treatment. Patients with heart failure or a history of pancreatitis should be particularly cautious when using this medication, and if acute pancreatitis symptoms develop, the medication should be discontinued immediately, and a healthcare provider should be consulted. Skin conditions such as bullous pemphigoid may occur, so if blisters or skin erosions develop, immediately inform healthcare personnel. The most common side effect while taking this medication is urinary tract infection; additionally, hypoglycemia, dehydration, increased urination, and skin rash may occur. In particular, if taken with insulin or sulfonylureas, the risk of hypoglycemia may increase; thus, careful monitoring of blood sugar levels is essential. This medication may lower blood pressure, so patients with hypotension or cardiovascular diseases should take caution. Moreover, while taking this medication, there is a rare possibility of acute perineal necrotizing infection, so if there is pain, swelling, or fever near the genital area, inform a doctor immediately. Pregnant or breastfeeding women are advised to avoid this medication; especially during breastfeeding, it is recommended to discontinue breastfeeding since the medication components may be transferred through breast milk. The safety and efficacy of this medication in children under the age of 18 have not been established, so it should not be used in this population. In cases of overdose, emergency treatment, such as removing the medication from the gastrointestinal tract, may be necessary, and appropriate measures should be taken following a physician's instructions. This medication should be stored out of reach of children and kept in its original packaging to maintain quality.

Side effects

  • Urinary tract infection
  • vaginal moniliasis
  • vulvitis
  • balanitis
  • other genital infections
  • hypersensitivity
  • angioedema
  • urticaria
  • hypoglycemia
  • thirst
Show 203 more
  • ketoacidosis
  • cough
  • constipation
  • pancreatitis
  • formation of oral ulcers
  • itching
  • rash
  • vesicular pemphigoid
  • rhabdomyolysis
  • blood volume depletion
  • increased urination
  • dysuria
  • interstitial nephritis
  • increased amylase
  • increased lipase
  • increased hematocrit
  • increased serum lipids
  • increased blood creatinine
  • decreased glomerular filtration rate
  • upper abdominal pain
  • enterocolitis
  • intestinal obstruction
  • gastroenteritis
  • herpes zoster
  • cystitis
  • acute pyelonephritis
  • bronchitis
  • vestibular neuronitis
  • sepsis
  • pneumonia
  • decreased appetite
  • dehydration
  • hyperglycemia
  • cerebral infarction
  • speech disorder
  • Alzheimer’s disease
  • chest pain
  • fever
  • facial swelling
  • fatigue
  • death
  • chronic obstructive pulmonary disease
  • asthma
  • diabetic foot
  • skin lesions
  • vascular stent stenosis
  • vascular stent thrombosis
  • acute kidney injury
  • end-stage kidney disease
  • acute cholangitis
  • acute cholecystitis
  • cholangitis
  • dizziness
  • kidney transplant failure
  • headache
  • oral burning syndrome
  • colitis
  • abdominal discomfort
  • dysphagia
  • gastric ulcer
  • gum bleeding
  • tooth loss
  • hemorrhoids
  • lower abdominal pain
  • diarrhea
  • vomiting
  • gastritis
  • acute pyelonephritis
  • onychomycosis
  • rhinitis
  • cellulitis
  • pharyngitis
  • scrub typhus
  • periodontitis
  • tonsillitis
  • laryngitis
  • chronic otitis media
  • paronychia
  • peritonsillar abscess
  • pulmonary tuberculosis
  • subcutaneous abscess
  • tinea corporis
  • dental abscess
  • tubo-ovarian abscess
  • vestibular neuritis
  • positional vertigo
  • sensory loss
  • paresthesia
  • amnesia
  • carotid stenosis
  • facial paralysis
  • memory impairment
  • neuralgia
  • Parkinsonism
  • polyneuropathy
  • sensory disturbance
  • drowsiness
  • CNS-origin dizziness
  • peripheral edema
  • facial swelling
  • peripheral swelling
  • facial swelling
  • chills
  • strange sensation
  • edema
  • pain
  • pain at the site of puncture
  • vascular stent thrombosis
  • weight gain
  • electrocardiogram abnormality
  • decreased hemoglobin
  • increased hemoglobin
  • Helicobacter test positive
  • urine red blood cells positive
  • ureteral calculi
  • hematuria
  • renal mass
  • urinary retention
  • abnormal urination
  • benign prostatic hyperplasia
  • erectile dysfunction
  • atrophic vaginitis
  • cervical dysplasia
  • cervical inflammation
  • scrotal pain
  • sexual dysfunction
  • vaginal discharge
  • hypoglycemia
  • obesity
  • hypersomnia
  • hyperlipidemia
  • vitamin D deficiency
  • dermoid cyst
  • seborrheic dermatitis
  • atopic dermatitis
  • nummular eczema
  • heat rash
  • sebaceous gland hyperplasia
  • lumbar spinal canal stenosis
  • myalgia
  • limb pain
  • musculoskeletal chest pain
  • arthralgia
  • cervical stenosis
  • fibromyalgia
  • flank pain
  • fracture pain
  • muscle weakness
  • osteoarthritis
  • osteoporosis
  • rotator cuff syndrome
  • astigmatism
  • allergic conjunctivitis
  • blurred vision
  • corneal erosion
  • macular fibrosis
  • ocular discomfort
  • ocular congestion
  • pathological myopia
  • retinal detachment
  • retinal crystals
  • retinal vein occlusion
  • traction retinal detachment
  • eyelid swelling
  • visual impairment
  • vitreous floaters
  • vitreous hemorrhage
  • epistaxis
  • age-related dyspnea
  • wet cough
  • allergic rhinitis
  • residual phlegm
  • skin laceration
  • rib fracture
  • ligamentous laxity syndrome
  • angina pectoris
  • palpitations
  • tachycardia
  • atherosclerosis
  • deep vein thrombosis
  • diabetic vascular complications
  • peripheral arterial occlusive disease
  • anxiety
  • depression
  • sleep disorders
  • acute cholecystitis
  • autoimmune hepatitis
  • cholelithiasis
  • hepatitis
  • otalgia
  • positional vertigo
  • lymphadenopathy
  • hypothyroidism
  • thyroid mass
  • vulvar pruritus
  • genital pruritus
  • dyslipidemia
  • diabetic retinopathy
  • dry eyes
  • chest discomfort
  • asthenia
  • pruritus
  • insomnia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. Additionally, the medication should be stored at room temperature between 1 and 30 degrees Celsius, avoiding extremely hot or cold places.

Appearance and packaging

Appearance

Pink film-coated tablet with a biconvex round shape

Package unit

Bottle - 30 tablets/bottle, Bottle - 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.